Lactate Dehydrogenase (LDH), Serum
Test Code: 302 | CPT Code: 83615 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Elevations in serum lactate dehydrogenase occur in myocardial infarction, liver disease, pernicious and megaloblastic anemias, pulmonary emboli, malignancies, muscular dystrophy etc. |
|
Run Day: Daily | |
Reporting Day: Same day |
Lactate, Plasma
Test Code: 7158 | CPT Code: 83605 |
Specimen Type: Whole blood in a gray-top (sodium fluoride) tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: This assay is useful in the diagnosis of lactatic acidosis which is typically observed in patients with short bowel syndrome and following jejuno-ileal |
|
Run Day: Daily | |
Reporting Day: 2nd day |
Lactic Acid/ Lactate, CSF
Test Code: 15992 | CPT Code: 83605 |
Specimen Type: CSF | |
Sample Volume: 2 mL | |
Transport Condition: Frozen | |
Specimen Rejection Criteria: Body fluid other than CSF | |
Methodology: Immunoassay | |
Special Requirements: Centrifuge to remove any cellular material. CSF is the only acceptable source. | |
Clinical Significance: Lactate found in CSF is predominantly produced by central nervous system glycolysis and is independent of serum lactate.Increased CSF lactate concentrations are related to increased cerebral glycolysis or hypoxia associated with bacterial meningitis, cerebral infarction, cerebral arteriosclerosis, intracranial hemorrhage, hydrocephalus, traumatic brain injury, cerebral edema, epilepsy, and inborn errors of metabolism. Lactate measurement in CSF can be used as a test to differentiate bacterial from viral meningitis. |
|
Run Day: Daily | |
Reporting Day: 2nd day |
Lamotrigine, Plasma
Test Code: 6915 | CPT Code: 80299 |
Specimen Type: Plasma EDTA | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Grossly hemolyzed | |
Methodology: HPTLC | |
Special Requirements: Instructions: Specimen should be collected at trough level (before the next dose). Clinical history is mandatory, name of the drug and dosage should be mentioned on the TRF. | |
Clinical Significance: Lamotrigine is an anticonvulsant drug used as an adjunctive treatment for refractory partial seizures. |
|
Run Day: Mon | |
Reporting Day: Sat |
Large Bowel, Colectomy for Nontumoral Conditions
Test Code: 1398 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Large Bowel, Colectomy for Tumor
Test Code: 1425 | CPT Code: 88309 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Large bowel, Polypectomy
Test Code: 1379 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Larynx, Endoscopic Incisional/Nodule Removal
Test Code: 1359 | CPT Code: 88309 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Larynx, Laryngectomy
Test Code: 1426 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
LDH Isoenzymes, Serum
Test Code: 6157 | CPT Code: 83625 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Electrophoresis | |
Special Requirements: Age & gender of the patient is mandatory for reporting | |
Clinical Significance: Diagnostic aid for myocardial infarction. Also for malignancies, anemias, and acute liver and muscle injuries. |
|
Run Day: Mon | |
Reporting Day: 4th day |
LDH, Body Fluids
Test Code: 1169 | CPT Code: 83615 |
Specimen Type: Any body fluid | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Grossly hemorrhagic | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: CSF LDH is useful to differentiate bacterial form viral meningitis. The CSF LDH levels are independent of serum concentrations. |
|
Run Day: Daily | |
Reporting Day: Same day |
LDL Cholesterol Subfractions, Serum
Test Code: 6804 | CPT Code: 83704 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: PAGE | |
Special Requirements: No special precautions needed | |
Clinical Significance: LDL cholesterol circulates as large buoyant (pattern A), intermediate & dense particles (pattern B). |
|
Run Day: Daily | |
Reporting Day: Next day |
LDL Cholesterol, Direct (LDL-D), Serum
Test Code: 1072 | CPT Code: 83721 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: Usually LDLcholesterol is measured in a fasting sample as part of lipid profile.Ideally fasting for 9-12 hours (water only) is required. However,some physicians may ask for non-fasting cholesterl testing to study the risk factors for CVD during routine checkup | |
Clinical Significance: LDL cholesterol is a key factor in the pathogenesis of atherosclerosis and coronary artery disease (CAD), while HDL cholesterol |
|
Run Day: Daily | |
Reporting Day: Same day |
Lead, Blood
Test Code: 1252 | CPT Code: 83655 |
Specimen Type: Whole blood in lavender-top (EDTA) tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: Age & gender of the patient is mandatory for reporting | |
Clinical Significance: Lead is distributed in the body into two pools, an active pool in the blood and soft tissues |
|
Run Day: Tue, Fri | |
Reporting Day: Next day |
Legionella Pneumophila Sero Group 1 IgM Antibodies, Serum
Test Code: 7133 | CPT Code: 86713 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Legionella pneumophila causes pulmonary disease in both normal and immuno-compromised hosts leading to legionnaires disease, pontiac fever and extra pulmonary infections, which are collectively referred to as legionellosis. |
|
Run Day: Wed | |
Reporting Day: 4th day |
Leishmaniasis (Visceral) Antibody, Serum (Rapid Kalazar Test)
Test Code: 8416 | CPT Code: 86717 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ Frozen condition | |
Specimen Rejection Criteria: Grosshemolysis and hyperlipemic | |
Methodology: Immunochromatography | |
Special Requirements: No special precautions needed | |
Clinical Significance: Visceral leishmaniasis (kala azar) is a disseminated intracellular protozoal (Leishmania spp) infection that targets primarily the reticuloendothelial system (liver, spleen, bone marrow), and can be fatal if untreated. Disease has a worldwide distribution, including the Middle East. Rapid kala azar test is used in the diagnosis of active visceral leishmaniasis. |
|
Run Day: Daily | |
Reporting Day: 3rd day |
Leptospira Antibodies, IgG, Serum
Test Code: 13454 | CPT Code: 86720 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis, hyperlipemic | |
Methodology: Enzyme immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Leptospirosis results from the direct or indirect exposure to urine from animals infected with leptospira. Illness ranges from self-limiting disease, to meningitis, to hepatorenal failure. This assay can be used as a serological diagnostic aid in leptospirosis. |
|
Run Day: Mon, Wed, Fri | |
Reporting Day: Same day |
Leptospira Antibodies, IgM, Serum
Test Code: 6956 | CPT Code: 86720 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Leptospirosis results from the direct or indirect exposure of urine from animals infected with Leptospira. Illness ranges from self-limiting disease, to meningitis, present in up to 40% |
|
Run Day: Mon, Wed, Fri | |
Reporting Day: Next day |
Leukemia Panel, Custom, (Four Surface Markers)
Test Code: 7132 | CPT Code: Use individual CPTCodes |
Specimen Type: Whole blood in lavender-top (EDTA) tube and green-top (sodium heparin) tube | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Flow cytometry | |
Special Requirements: Clinical history is essential | |
Clinical Significance: The leukemia evalution employs cell surface markers to aid in the diagnosis and characterisation of neoplasms of hematopoietic origin. Results are useful in the |
|
Run Day: Daily | |
Reporting Day: 3rd day |
Levetiracetam, Serum
Test Code: 13907 | CPT Code: 80177 |
Specimen Type: Serum (red/ yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition/ frozen | |
Specimen Rejection Criteria: Nil | |
Methodology: Liquid Chromatography | |
Special Requirements: Draw blood immediately before next scheduled dose. Clinical history, including drug history required | |
Clinical Significance: Levetiracetam is used for treatment of partial, myoclonic, and tonic-clonic seizures, and is used also for manic states and migraine prophylaxis. This assay is used for monitoring serum concentration of levetiracetam, particularly in patients with renal disease, assessing compliance, and assessing potential toxicity of the drug. |
|
Run Day: Daily | |
Reporting Day: 8th day |
Lip V excision
Test Code: 1381 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Lipase, Serum
Test Code: 6156 | CPT Code: 83690 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Hemolysis and lipemia | |
Methodology: Spectrophotometry | |
Special Requirements: Clinical history, age & gender | |
Clinical Significance: Confirmatory evidence for diagnosis of pancreatitis |
|
Run Day: Daily | |
Reporting Day: Same day |
Lipid Profile (Total Cholesterol, Triglyceride, LDL cholesterol, HDL Cholesterol, VLDLCholesterol)
Test Code: 495 | CPT Code: 80061 |
Specimen Type: Serum collected in a yellow-top tubes | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: 12 to 14 hrs fasting specimen is preferred | |
Clinical Significance: The lipid profile components are useful in the detection, classification and monitoring of patients with hyperlipidemia. |
|
Run Day: Daily | |
Reporting Day: Same day |
Lipid Profile with Direct LDL
Test Code: 6860 | CPT Code: 80061 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: Ideally fasting for 9-12 hours (water only) is required.However,some physicians may ask for non-fasting lipid testing to study the risk factors for CVD during routine checkup. | |
Clinical Significance: The lipid profile components are useful in the detection, classification and monitoring of patients with hyperlipidemia. |
|
Run Day: Daily | |
Reporting Day: Same day |
Lipoprotein (a) [LP(a)], Serum
Test Code: 1294 | CPT Code: 83695 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoturbidometry | |
Special Requirements: 12 to 14 hrs fasting specimen is preferred | |
Clinical Significance: Elevated concentration of Lp(a) are associated with increased risk of coronary artery diseases. |
|
Run Day: Daily | |
Reporting Day: 3rd day |
Lipoprotein Electrophoresis, Serum
Test Code: 3617 | CPT Code: 83700 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Electrophoresis | |
Special Requirements: 12 to 14 hrs fasting specimen is preferred | |
Clinical Significance: This test is useful in the detection, classification and monitoring of patients with hyperlipidemia. |
|
Run Day: Tue, Thurs, Sat | |
Reporting Day: 5th day |
Lithium, Serum
Test Code: 1076 | CPT Code: 80178 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: ISE | |
Special Requirements: Age & gender of the patient is mandatory for reporting | |
Clinical Significance: Lithium is used in the treatment of both manic and depressive phases of bipolar disorder, as well as in unipolar depressive disorder to prevent future depressive episodes. The clinical presentation and patient history dictate the necessity and frequency of measuring serum lithium concentrations. Elderly patients taking lithium should be more closely monitored for signs of lithium toxicity. Lithium toxicity should be considered in the context of both chronic intoxication and acute ingestion. |
|
Run Day: Daily | |
Reporting Day: 2nd day |
Liver Function Panel Total (bilirubin , Direct Bilirubin, Alkaline phosphatase , SGOT , SGPT, Total Protein ,,Albumin, Indirect bilirubin )
Test Code: 22633 | CPT Code: 80076 |
Specimen Type: Serum collected in a yellow top tube | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: see individual assay. |
|
Run Day: Daily | |
Reporting Day: Same day |
Liver Function Tests (Total Bilirubin, Direct Bilirubin, Indirect Bilirubin, ALP, SGOT, SGPT, TotalProtein, Albumin, GGT)
Test Code: 492 | CPT Code: 80076 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: see individual assay. |
|
Run Day: Daily | |
Reporting Day: Same day |
Liver Kidney Microsome Autoantibodies, Serum
Test Code: 6909 | CPT Code: 86376 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Grosshemolysis, lipemia | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: The presence of LKM-1 Antibodies can be used in conjunction with clinical findings and other laboratory tests to aid in the diagnosis of autoimmune liver diseases such as autoimmune hepatitis (AIH-2) |
|
Run Day: Sat | |
Reporting Day: Next day |
Liver, Excision Biopsy
Test Code: 1427 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Liver, Needle biopsy
Test Code: 1360 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Lung, Bronchoscopic Biopsy
Test Code: 1352 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: formalin-fixed, paraffin-embedded tissue block | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Lung, Needle Biopsy
Test Code: 1361 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Lung, Resection (Pneumonectomy) for Nontumoral Conditions
Test Code: 1399 | CPT Code: 88309 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Lung, Resection for Tumor
Test Code: 1428 | CPT Code: 88309 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Lupus Anticoagulant, Plasma
Test Code: 6155 | CPT Code: Use individual CPTCodes |
Specimen Type: Citrated plasma [Whole blood in blue-top (sodium citrate) tube] | |
Sample Volume: 2.0 mL | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Clot Detection | |
Special Requirements: Clinical history is mandatory | |
Clinical Significance: Lupus anticoagulants (LA) are members of a family of Antibodies with phospholipid specificity. LA may be defined as an immunoglobulin, IgG or IgM or a mixture of both, that interferes with one or more of the in vitro phospholipid (PL) dependent tests of coagulation. These antibodies are not associated with a |
|
Run Day: Wed | |
Reporting Day: Next day |
Luteinizing Hormone (LH), Serum
Test Code: 480 | CPT Code: 83002 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: ECLIA | |
Special Requirements: Clinical history and time of Specimen collection is essential | |
Clinical Significance: This test is useful in the differential diagnosis of pituitary and gonadal insufficiency and in children with precocious puberty. |
|
Run Day: Daily | |
Reporting Day: Same day |
Lymph Node Dissection, Multiple Inguinal / Axillary
Test Code: 1400 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Lymph Node Dissection, Radical Neck, Retroperitoneal
Test Code: 1429 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Lymph Node Excision Biopsy, Large Node
Test Code: 1380 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Lymph Node Incisional Biopsy, Less than 2 cm in size
Test Code: 1362 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Lymph Node, Staging Laparotomy for Malignant Lymphoma
Test Code: 1436 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Lymphoma, Differential Diagnosis (CD30, CD15, CD20, CD3, CD45), IHC
Test Code: 17163 | CPT Code: 88342x 5 |
Specimen Type: Tissue in 10% formalin/ formalin fixed paraffin embedded tissue block | |
Sample Volume: 1 cm/ 1 block | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Nil | |
Methodology: Immunohistochemistry | |
Special Requirements: Clinical history is required | |
Clinical Significance: Cellular immunophenotyping by immunohistochemistry, in conjunction with morphologic assessment, aids in establishing a diagnosis of lymphomas. It is also an essential component in sub-classification of lymphomas. |
|
Run Day: Daily | |
Reporting Day: 5th day |